Sung H, Ferly J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Matsuda T, Ajiki W, Marugame T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41:40–51.

Article  PubMed  Google Scholar 

Oh CM, Won YJ, Jung KW, et al. Community of population-based regional cancer registries cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436–50.

Article  PubMed  PubMed Central  Google Scholar 

Huang RJ, Koh H, Hwang JH, et al. A summary of the 2020 gastric cancer summit at Stanford university. Gastroenterology. 2020;159:1221–6.

Article  PubMed  Google Scholar 

Suh M, Song S, Cho HN, et al. Trends in participation rates for the national cancer screening program in Korea, 2002–2012. Cancer Res Treat. 2017;49:798–806.

Article  PubMed  Google Scholar 

Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality. Gastroenterology. 2017;152(1319–28): e7.

Google Scholar 

Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.

Article  PubMed  Google Scholar 

Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One. 2013;8: e79088.

Article  PubMed  PubMed Central  Google Scholar 

Hamashima C. On behalf of the systematic review group and guideline development group for gastric cancer screening guidelines. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2018;48:673–83.

Article  PubMed  Google Scholar 

Inoue K, Fujisawa T, Haruma K. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Bio Mark. 2010;25:207–12.

Article  Google Scholar 

Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445–57.

Article  CAS  PubMed  Google Scholar 

Gotoda T, Ishikawa H, Ohnishi H, et al. Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy. Gastric Cancer. 2015;18:605–11.

Article  PubMed  Google Scholar 

Matsuda T, Marugame T, Tamo K, et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2012;42:139–47.

Article  PubMed  Google Scholar 

Terasawa T, Nishida H, Kato K, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One. 2014;9: e109783.

Article  PubMed  PubMed Central  Google Scholar 

Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663–72.

Article  PubMed  PubMed Central  Google Scholar 

Taniyama Y, Katanoda K, Charvat H, et al. Estimation of lifetime cumulative incidence and mortality risk of gastric cancer. Jpn J Clin Oncol. 2017;47:1097–102.

Article  PubMed  PubMed Central  Google Scholar 

Li WQ, Qin XX, Li ZX, et al. Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study. Endoscopy. 2022;54:848–58.

Article  PubMed  Google Scholar 

Noh CK, Lee E, Lee GH, et al. Association of regular endoscopic screening with interval gastric cancer incidence in the national cancer screening program. J Clin Med. 2021;11:230.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Nishiyama T, Kikuchi S, et al. Changing trends in the prevalence of H. pylori infection in Japan (1908–2003): a systematic review and meta-regression analysis of 170,752 individuals. Sci Rep. 2017;7:15491.

Article  PubMed  PubMed Central  Google Scholar 

Ueda J, Gosho M, Inui Y, et al. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter. 2014;19:105–10.

Article  PubMed  Google Scholar 

Takahashi Y, Yamamich N, Kubota D, et al. Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study. Gastric Cancer. 2022;25:481–9.

Article  CAS  PubMed  Google Scholar 

Kowada A. Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. Scand J Gastroenterol. 2019;54:685–9.

Article  PubMed  Google Scholar 

Inoue M, Sawada N, Goto A, et al. High-negative anti-Helicobacter pylori IgG antibody titers and long-term risk of gastric cancer: Results from a large-scale population-based cohort study in Japan. Cancer Epidemiol Biomark Prev. 2020;29:420–6.

Article  CAS  Google Scholar 

Hamashima C, Yoshimura K, Fukao A. A study protocol for expanding the screening interval of endoscopic screening for gastric cancer based on individual risks: prospective cohort study of gastric cancer screening. Ann Transl Med. 2020;8:1604.

Article  PubMed  PubMed Central  Google Scholar 

Luu XQ, Lee K, Jun JK, et al. Effect of gastric cancer screening on long-term survival of gastric cancer patients: result of Korean national cancer screening program. J Gastroenterol. 2022;57:464–75.

Article  PubMed  Google Scholar 

Wang C, Nishiyama T, Kikuchi S, et al. Changing trends in the prevalence of H. pylori infection in Japan (1908–2003): a systematic review and meta-regression analysis of 170,752 individuals. Sci Rep. 2017;14:15491.

Article  Google Scholar 

Kowada A, Asaka M. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: a cost-effectiveness analysis. Helicobacter. 2021;26: e12837.

Article  PubMed  PubMed Central  Google Scholar